ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2939

Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-Analysis

Patompong Ungprasert1, Matthew J. Koster2 and Kenneth J. Warrington3, 1Rheumatology, Mayo Clinic, Rochester, MN, 2Rheumatology, University of California Los Angeles, CA, USA Mayo Clinic, Rochester, MN, 3Rheumatology, University of California Los Angeles, CA, USA Mayo, Rochester, MN

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: ANCA, giant cell arteritis, meta-analysis, thrombosis and vasculitis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Vasculitis - Poster III: Rarer Vasculitides

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-analysis

Background/Purpose: Venous thromboembolism (VTE) is a common medical problem with a significant morbidity and mortality. Chronic inflammatory state has been increasingly recognized as an important risk factor for VTE.  Several immune-mediated inflammatory disorders, such as systemic lupus erythematosus and rheumatoid arthritis, are associated with increased incidence of VTE in epidemiologic studies. Systemic vasculitides are group of immune-mediated inflammatory disorders characterized by inflammation in blood vessels. Apart from Behcet’s disease, it is unclear if these disorders are also associated with increased risk of VTE due to limited data. To further investigate this possible association, we conducted a systematic review and meta-analysis of observational studies that compared the risk of VTE in patients with systemic vasculitides versus participants without systemic vasculitides.

Methods: Two investigators independently searched published studies indexed in MEDLINE, EMBASE and the Cochrane database from inception to March 2015 using the terms for each type of vasculitis in conjunction with the terms for venous thromboembolism. A manual search of references of retrieved articles was also performed. The inclusion criteria were as follows: (1) observational studies evaluating the association between vasculitis and VTE and (2) odds ratios, relative risk (RR) or hazard ratio or standardized incidence ratio with 95% confidence intervals (CI) were provided. Study eligibility was independently determined by the two investigators noted above. Newcastle-Ottawa scale was used to assess the quality of included studies. RevMan 5.3 software was used for the data analysis.  Point estimates and standard errors were extracted from individual studies and were combined by the generic inverse variance method of DerSimonian and Laird.  Given the high likelihood of between study variance, we used a random-effect model rather than a fixed-effect model.  Statistical heterogeneity was assessed using the Cochran’s Q test. 

Results: Seven studies investigating the risk of VTE among patients with granulomatosis with polyangiitis (GPA), polyarteritis nodosa (PAN) and giant cell arteritis (GCA) were identified. Elevated risk were seen in all three vasculitides (GPA, pooled RR 3.94, 95% CI 1.11 – 14.01; PAN, pooled RR 3.00, 95% CI 2.20 – 4.09; GCA, pooled RR 2.26, 95% CI 1.38 – 3.71). Forest plots are demonstrated in figure 1A-1C, respectively.

Conclusion: Our study demonstrated a statistically significant increased VTE risk among patients with GPA, PAN and GCA.


Disclosure: P. Ungprasert, None; M. J. Koster, None; K. J. Warrington, None.

To cite this abstract in AMA style:

Ungprasert P, Koster MJ, Warrington KJ. Risk of Venous Thromboembolism in Patients with Systemic Vasculitides: A Systematic Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/risk-of-venous-thromboembolism-in-patients-with-systemic-vasculitides-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/risk-of-venous-thromboembolism-in-patients-with-systemic-vasculitides-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology